• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT LABORATORIES PRISM HCV; ANTI-HCV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT LABORATORIES PRISM HCV; ANTI-HCV Back to Search Results
Catalog Number 06D18-68
Medical Device Problem Code False Positive Result (1227)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 06/24/2019
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.Patient identifier: multiple = (b)(6).Patient information: no further donor information was provided.
 
Event or Problem Description
The customer reported false repeat reactive abbott prism hcv results for two donor samples.The customer indicated the donors' previous and subsequent donation were non-reactive.Donor 1: (b)(6) 2019 id (b)(6) non-reactive, (b)(6) 2019 id (b)(6) repeat reactive, (b)(6) 2019 id (b)(6) non-reactive.Donor 2: (b)(6) 2019 id (b)(6)non-reactive, (b)(6) 2019 id (b)(6) repeat reactive, (b)(6) 2019 id (b)(6) non-reactive.No impact to donor management was reported.
 
Additional Manufacturer Narrative
Investigation of the customer issue included a review of the complaint text, a search for similar complaints, review of the manufacturing documentation, review of field data, and a review of labeling.Return testing was not completed as returns were not available.Review of complaint trending reports did not identify any trends for the abbott prism hcv assay.Review of complaint activity determined that there is normal complaint activity for reagent lot 03109m700.Field data was reviewed to evaluate initial reactive rate, repeat reactive rate and specificity of reagent lot 03109m700.The initial reactive rate was 0.10% and repeat reactive rate was 0.08%, which are within package insert specifications.Additionally, assuming a zero prevalence of hcv for the tested samples, the specificity of lot 03109m700 would be within package insert specifications.Manufacturing documentation for the reagent lot did not identify any issues associated with the complaint issue.Additionally, a review of labeling concluded that the issue was sufficiently addressed.Based on the available information, no systemic issue or deficiency of the abbott prism hcv assay was identified.
 
Additional Manufacturer Narrative
An error was identified on february 13, 2020.The incorrect product code of mzo (section d.2b) was used in the previous submissions.The correct code is qhm, this report is being submitted to correct the product code.No further changes or corrections to the product information or evaluation are needed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRISM HCV
Common Device Name
ANTI-HCV
Manufacturer (Section D)
ABBOTT LABORATORIES
100 abbott park road
abbott park IL 60064 3500
MDR Report Key9475721
Report Number1415939-2019-00231
Device Sequence Number14175608
Product Code QHM
UDI-Device Identifier00380740062996
UDI-Public00380740062996
Combination Product (Y/N)N
Initial Reporter StateTN
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source health professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 03/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/17/2020
Device Catalogue Number06D18-68
Device Lot Number03109M700
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 12/03/2019
Supplement Date Received by Manufacturer12/20/2019
02/13/2020
Initial Report FDA Received Date12/16/2019
Supplement Report FDA Received Date01/09/2020
03/09/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
(B)(6) AND 1422.; 01399-96 AND 1422; ABBOTT PRISMNEXT 6 CHANNEL ANALYZER,; ABBOTT PRISMNEXT 6 CHANNEL ANALYZER,; ABBOTT PRISMNEXT 6 CHANNEL ANALYZER,; AND 1422; LIST 06A36-11, SERIALS (B)(6) ,; LIST 06A36-11, SERIALS (B)(6) ,; LIST 06A36-11, SERIALS (B)(6) , (B)(6)
-
-